Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment satisfaction in multiple sclerosis.
Monoclonal antibodies in MS: mechanisms of action.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Estrogen treatment in multiple sclerosis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
The challenge of comorbidity in clinical trials for multiple sclerosis.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
SigmaPharm Laboratories Products
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.

Pages